Glorifarm Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -100.00%
- Profit Growth -471.66%
- Ebitda -490.19%
- Net Worth -281.34%
- Total Assets -18.71%
About Glorifarm Biosciences
Glorifarm Biosciences Private Limited (GBPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2020 (Four years and eight months 1 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Madhavan Vaiyapuri, Chellammal Ramasamy, and Vijai Madhavan serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01100KA2020PTC134567
-
Company No.
134567
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jun 2020
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Glorifarm Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijai Madhavan
|
Director | 03-Jun-2020 | Current |
|
Madhavan Vaiyapuri
|
Director | 03-Jun-2020 | Current |
|
Chellammal Ramasamy
|
Director | 03-Jun-2020 | Current |
Financial Performance of Glorifarm Biosciences.
Glorifarm Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 471.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 281.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glorifarm Biosciences?
In 2023, Glorifarm Biosciences had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sai Skand Enterprises Private LimitedMadhavan Vaiyapuri, Chellammal Ramasamy and 1 more are mutual person
-
Sundance Estates Private Limited
Madhavan Vaiyapuri and Chellammal Ramasamy are mutual person
-
Glorifarm Botanicals Private Limited
Madhavan Vaiyapuri, Chellammal Ramasamy and 1 more are mutual person
-
Verita Agrofoods Private Limited
Madhavan Vaiyapuri and Chellammal Ramasamy are mutual person
-
Sidvik Agro Foods Private Limited
Madhavan Vaiyapuri and Chellammal Ramasamy are mutual person
-
Pax Fashions Private Limited
Madhavan Vaiyapuri and Chellammal Ramasamy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glorifarm Biosciences?
Glorifarm Biosciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glorifarm Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glorifarm Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.